PCDD/F Emission from Pharmaceutical Industries
نویسندگان
چکیده
منابع مشابه
Preventing Insider Theft: Lessons from the Casino and Pharmaceutical Industries
Through structured interviews and a literature review, we assess which approaches to protection against insider thefts in the casino and pharmaceutical industries could be usefully applied to strengthen protections against insider theft in the nuclear industry, where insider thefts could have very high consequences. Among other measures, we suggest consideration of constant video surveillance o...
متن کاملConsultants to the Pharmaceutical and Allied Industries
The petitioner requests that the Commissioner of the Food and Drug Administration declare that the drug product Divalproex Sodium Extended-Release Tablets, 1000 mg, is suitable for submissiol as an ANDA. The reference-listed drug product upon which this petition is based is Depakote ER (Divalproex Sodium) Extended-Release Tablets, 500 mg manufactured by Abbott Laboratories. The approval of whic...
متن کاملFrom maturity to value-added innovation: lessons from the pharmaceutical and agro-biotechnology industries.
The pharmaceutical and agro-biotechnology industries have been confronted by dwindling product pipelines and rapid developments in life sciences, thus demanding a strategic rethink of conventional research and development. Despite offering both industries a solution to the pipeline problem, the life sciences have also brought complex regulatory challenges for firms. In this paper, we comment on...
متن کاملRobust Batch Process Scheduling in Pharmaceutical Industries: A Case Study
Batch production plants provide a wide range of scheduling problems. In pharmaceutical industries a batch process is usually described by a recipe, consisting of an ordering of tasks to produce the desired product. In this research work we focused on pharmaceutical production processes requiring the culture of a microorganism population (i.e. bacteria, yeasts or antibiotics). Several sources of...
متن کاملInvestigating Human Factors in Biotechnology and Pharmaceutical Manufacturing industries
The aim of this paper is to present the work carried out in a European Commission-funded project to adapt an existing Aircraft Maintenance Human Factors (HF) training program (STAMINA) to the Biotechnology and Pharmaceutical Manufacturing industries (BPM). The STAMINA approach has been successfully built into a global human factors training business recognized internationally as a quality bench...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Aerosol and Air Quality Research
سال: 2019
ISSN: 1680-8584,2071-1409
DOI: 10.4209/aaqr.2019.06.0284